SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-032131
Filing Date
2022-06-10
Accepted
2022-06-10 09:25:32
Documents
12
Period of Report
2022-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161424-8k_nektar.htm   iXBRL 8-K 35399
  Complete submission text file 0001213900-22-032131.txt   206793

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20220608.xsd EX-101.SCH 3027
3 XBRL LABEL FILE nktr-20220608_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE nktr-20220608_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT ea161424-8k_nektar_htm.xml XML 3491
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 221007782
SIC: 2834 Pharmaceutical Preparations